LEADER 02265nam0-2200589 --450 
001 9910646997403321
005 20240311132128.0
010   $a0121819701
100   $a20230224d1980----kmuy0itay5050    ba
101 0 $aeng
102   $aUS
105   $aa       001yy
200 1 $aImmunochemical techniques$fedited by Helen Van Vunakis, John J. Langone, Di Sabato
210   $aNew York [etc.]$cAcademic Press$d1980-
215   $av.$cill.$d24 cm
225 0 $aMeethods in Enzymology$v70, 73-74, 84, 92-93, 108, 116, 121, 132, 150, 162
300   $aI primi 6 v. senza titolo proprio sotto il titolo: Methods in enzymology
327   $a70: Part A ; 73: Part B ; 74: Part C ; 84: Part D ; 92: Part E ; 93: Part F ; 108: Part G ; 116: Part H ; 121: Part I ; 132: Part J, Phagocytosis and cell-medical.. ; 150: Part K, In vito models of b and T cell functions? ; 162: Part L, Chemiotaxis and inflammation
517 1 $aImmunochemical techniques
610 0 $aChimica immunologica
676   $a572$v23$zita
702  1$aLangone,$bJohn Joseph
702  1$aVan Vunakis,$bHelen
702  1$aDi Sabato,$bGiovanni
801  0$aIT$bUNINA$gREICAT$2UNIMARC
901   $aBK
912   $a9910646997403321
952   $aBSF-MET.ENZ.-1 (70$b913$fSC1
952   $aBSF-MET.ENZ.-1 (73$b916$fSC1
952   $aBSF-MET.ENZ.-1 (74$b6395$fSC1
952   $aBSF-MET.ENZ.-1 (84$b926$fSC1
952   $aBSF-MET.ENZ.-1 (92$b934$fSC1
952   $aBSF-MET.ENZ.-1 (93$b935$fSC1
952   $aBSF-MET.ENZ.-1 (108$b949$fSC1
952   $aBSF-MET.ENZ.-1 (116$b957$fSC1
952   $aBSF-MET.ENZ.-1 (121$b962$fSC1
952   $aBSF-MET.ENZ.-1 (132$b973$fSC1
952   $aBSF-MET.ENZ.-1 (150$b991$fSC1
952   $aA MIC 1-70$b3303/2024$fFAGBC
952   $aA MIC 1-73$b3306/2024$fFAGBC
952   $aA MIC 1-74$b3307/2024$fFAGBC
952   $aA MIC 1-84$b3317/2024$fFAGBC
952   $aA MIC 1-92$b3325/2024$fFAGBC
952   $aA MIC 1-93$b3326/2024$fFAGBC
952   $aA MIC 1-121$b3342/2024$fFAGBC
952   $aA MIC 1-132$b3352/2024$fFAGBC
952   $aA MIC 1-150$b3368/2024$fFAGBC
952   $aA MIC 1-162$b3380/2024$fFAGBC
959   $aSC1
959   $aFAGBC
996   $aImmunochemical techniques$984880
997   $aUNINA